Literature DB >> 12701992

Practical tips for warfarin dosing and monitoring.

Amir Jaffer1, Lee Bragg.   

Abstract

Patients on warfarin and their physicians must constantly balance the risks of bleeding and clotting. We offer practical tips for safe and effective warfarin therapy, based on the practices of the Anticoagulation Clinic of The Cleveland Clinic.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12701992     DOI： 10.3949/ccjm.70.4.361

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  13 in total

Review 1.  Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation.

Authors:  R Katira; A Chauhan; R S More
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

2.  Warfarin overdose: a 25-year experience.

Authors:  Michael Levine; Anthony F Pizon; Angela Padilla-Jones; Anne-Michelle Ruha
Journal:  J Med Toxicol       Date:  2014-06

3.  Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.

Authors:  R A Smulders; M E Kuipers; W J J Krauwinkel
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

4.  Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario.

Authors:  Devendra Saksena; Yugal K Mishra; S Muralidharan; Vivek Kanhere; Pankaj Srivastava; C P Srivastava
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-28

5.  Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Deok Hwi Lim; Woo Jeong Ok; Gi Suk Nam; Min Ji Kim; Ho-Kyun Kwon; Jun-Hee Noh; Je-Young Lee; Hyun-Hong Kim; Jong-Lae Kim; Hwa-Jin Park
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

6.  Characteristics of patients with thromboembolic disorders on warfarin therapy in resource limited settings.

Authors:  Zipporah Kamuren; Gabriel Kigen; Alfred Keter; Alice Maritim
Journal:  BMC Health Serv Res       Date:  2018-09-19       Impact factor: 2.655

7.  The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients.

Authors:  Jung Nam An; Shin Young Ahn; Chang-Hwan Yoon; Tae-Jin Youn; Moon-Ku Han; Sejoong Kim; Ho Jun Chin; Ki Young Na; Dong-Wan Chae
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

Review 8.  How to manage warfarin therapy.

Authors:  Philip A Tideman; Rosy Tirimacco; Andrew St John; Gregory W Roberts
Journal:  Aust Prescr       Date:  2015-04-01

9.  Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran.

Authors:  Christopher J Boos; Ranjit S More
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-04-22

10.  Association between satisfaction with and adherence to warfarin therapy on the control of international normalized ratio: A hospital-based study in Saudi Arabia.

Authors:  Balkhi Balkhi; Mabrouk Al-Rasheedi; Abuabker Ibrahim Elbur; Ahmad Alghamadi
Journal:  Saudi Pharm J       Date:  2017-11-28       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.